From Medscape Neurology

Coverage from the

Consortium of Multiple Sclerosis Centers (CMSC) 2021 Annual Meeting

October 25 - 28, 2021; Orlando, Florida + Virtual

October 25 - 28, 2021 Orlando, Florida + Virtual
  • CMSC 2021 B-Cell Repletion Common With MS Drug, but No Symptom Worsening Although some repletion of B cells occurs with the B-cell depleting MS drug ocrelizumab, the effect does not appear to be associated with symptom worsening or a 'wearing off' effect.
  • CMSC 2021 Two Diets Linked to Improved Cognition, Fatigue in MS Paleolithic elimination and low-saturated fat diets are associated with improvements in fatigue, cognitive dysfunction, and quality of life in patients with multiple sclerosis, new research suggests.

Conference News

Popular News from CMSC 2020

  • Cannabis Misconceptions Still Common Among MS Clinicians Cannabis Misconceptions Still Common Among MS Clinicians Despite important implications in the management of MS, clinicians often have little training or knowledge of the wide variations of cannabis.
  • Telerehabilitation May Be Effective in MS Telerehabilitation May Be Effective in MS Telerehabilitation is safe, may offer functional benefits comparable to those of outpatient rehabilitation for patients with MS and impaired mobility, and also saves time and travel costs.
  • Influenza Vaccine Efficacy 'Undiminished' in MS Influenza Vaccine Efficacy 'Undiminished' in MS The efficacy of the influenza vaccine when given to patients with multiple sclerosis is similar to that in healthy controls, according to an analysis of nine published cohort studies.

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage